Overcoming Immune Checkpoint Inhibitor Resistance with Potent, Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides
Article Details
Journal Info
Journal of the American Chemical Society
American Chemical Society
Authors (12)
Anna Lechner
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Peter A. Jordan
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Gabriella Costa Machado da Cruz
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Jacob Lamson
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Jessica Gordon
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Bethany K. Okada
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Kelsey Anderson
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Rajan Chaudhari
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Christopher J. Rosario
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Jasmine Mikesell
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Scott A. McPhee
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States
Mark J. Burk
Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States